Temple, founded by Deepinder Goyal, has revealed an updated, more compact design for its brain-health focused wearable, claiming it as the smallest and most powerful device of its kind. The device is expected to begin shipping before the end of 2026, with pre-orders opening soon.
- Temple’s new wearable is less than half the size of earlier versions.
- $54M seed funding highlights growing investor interest.
- Device linked to research on blood flow's impact on brain aging.
What happened
Deepinder Goyal’s startup Temple has disclosed a redesigned version of its wearable device that measures cerebral blood flow, critical for understanding brain health and aging. The new design is reportedly less than half the size of previous prototypes, making it the smallest volumetrically among wearables on the market. The device is also touted as the most powerful in its category, positioning it as a leading product ahead of its first shipment planned for late 2026.
While detailed specifications and pricing are yet to be announced, Temple has opened limited pre-orders and has already shipped an initial batch of 100 devices. The company works with manufacturing partners Zetwerk and Ethereal Machines but retains core production in-house. This development follows a significant $54 million seed funding round led by investors like Steadview Capital and Info Edge Ventures, which values Temple at approximately $375 million.
Why it matters
Temple’s wearable is notable for integrating a unique scientific hypothesis from Goyal’s Continue Research, which suggests that gravity’s effect on cerebral blood flow could explain some aspects of brain aging. By enabling users to measure their brain’s blood flow, the device may offer novel insights into longevity and mental health, pushing beyond traditional fitness tracking features.
This launch exemplifies broader trends in India’s healthtech sector, where startups are exploring innovative wearable form factors beyond smartwatches. Competing products include health-focused smart rings and EEG-based devices that track mental wellness, marking growing diversity and sophistication in the wearable market projected to reach $4.4 billion by 2034, growing at nearly 15% annually.
What to watch next
Stakeholders should monitor Temple’s upcoming pre-order phase and the eventual commercial rollout to gauge consumer adoption and market reaction. Details on pricing, user interface, and integration with longevity research will be key indicators of its potential impact and scalability as a standalone health device.
Additionally, observing how Temple navigates the competitive wearable landscape—including rivals developing smart rings and biosensing chips—will clarify its differentiation strategy and long-term viability. The company’s ability to convert scientific theory into practical consumer health benefits could set new standards for brain health monitoring technology.